Spirulina Market by Type (Arthrospira Platensis and Arthrospira Maxima), Application (Nutraceuticals, Cosmetics, Food & Beverages, Animal Feed, and Others), and Drug Formulation (Powder, Tablet & Capsule, Liquid, and Granule & Gelling Agent): Global Opportunity Analysis and Industry Forecast, 20192026
- Published Date: 2020-10-18
- Report ID: 3498
- Pages: 210
-
Format:
Spirulina is a natural algae powder known as cyanobacteria that comprises potent level of proteins, antioxidants, and vitamin B and other nutrients. Spirulina exhibits various benefits such as lowering of LDL and triglyceride levels and anticancer properties. It also reduces blood pressure, is effective against anemia, and improves muscle strength. The global spirulina market generated $346 million in 2018, and is projected to reach $779 million by 2026, growing at a CAGR of 10.6% from 2019 to 2026.
The increase in use of spirulina as a dietary food supplement, owing to its high nutritional content is the major factor that drives the spirulina market. Furthermore, increase in adoption of healthy food in developed countries fuel the market growth of spirulina in food & beverages. The rise in prevalence of cancer, cardiovascular diseases, immune diseases, and other diseases boosts the demand of spirulina.
Furthermore, increase in healthcare expenditure and disposable income among the population is anticipated to increase the market growth. However, limited resource of spirulina as it is extracted from the freshwater sources that are available in very few areas hinders the market growth. Emerging economies such as India, China, Mexico, and Brazil are anticipated to provide new opportunities for the market growth during the forecast period.
The global spirulina market is segmented into type, application, drug formulation, and region. By type, the market is bifurcated into Arthrospira Platensis and Arthrospira Platensis. Based on application, it is categorized into nutraceuticals, cosmetics, food & beverages, agriculture, feed, and others. Based on drug formulation, the spirulina market is categorized into powder, tablet & capsule, liquid, and granule & gelling agent. Based on region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
KEY BENEFITS FOR STAKEHOLDERS
This report highlights the market dynamics to understand the global spirulina market and capitalize on the prevailing opportunities.
Quantitative analysis of the current market and forecasts would assist stakeholders to design business strategies accordingly.
Porter's five forces analysis examines the competitive market structure and provides a deeper understanding of the influencing factors for entry and expansion.
Pin-point analysis of geographical segments offers identification of most profitable segments to capitalize on.
KEY MARKET SEGMENTS
By Type
o Arthrospira Platensis
o Arthrospira Maxima
By Application
o Nutraceuticals
o Food & Beverages
o Cosmetics
o Animal Feed
o Others
By Drug Formulation
o Powder
o Tablet & Capsule
o Liquid
o Granule & Gelling Agent
By Region
o North America
U.S.
Canada
Mexico
o Europe
Germany
France
Spain
Italy
UK
Rest of Europe
o Asia-Pacific
Australia
Japan
India
China
Rest of Asia-Pacific
o LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA
KEY MARKET PLAYERS
Cyanotech
DIC Corporation
Chr. Hansen Holding A/S
Dongtai City Spirulina Bio-engineering Co., Ltd.
Algenol Biofuels Inc
Prolgae
Sensient Technologies Corporation
Parry Neutraceuticals
Algatec
The other players in the value chain include (profiles not included in the report):
GNC Holdings, Inc.
Now Health Group Inc.
Fuqing King Dnarmsa Spirulina Co.
Fraken Biochem Co., Ltd.
Far East Bio-Tec Co. Ltd.
CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.4. Research methodology
1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings
2.1.1. Top impacting factors
2.1.2. Top investment pockets
2.2. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Parent Market Overview
3.3. Key Forces Shaping Spirulina Market
3.3.1. Low-to-high bargaining power of suppliers
3.3.2. Moderate-to-high threat of new entrants
3.3.3. Moderate threat of substitutes
3.3.4. Moderate intensity of rivalry
3.3.5. Low-to-moderate bargaining power of buyers
3.4. Pricing Analysis
3.4.1. Pricing Analysis, By Region, 2018 & 2025
3.5. Value Chain Analysis
3.6. Impact of government regulations on global spirulina market
3.7. Industry Pain point analysis
3.8. Patent Analysis
3.8.1. By Region (2016-2018)
3.8.2. By Applicant
3.9. Case Studies
3.9.1. Case Study 01
3.10. Market dynamics
3.10.1. Drivers
3.10.1.1. Rise in demand for natural ingredient
3.10.1.2. Promotion of the production of spirulina by government
3.10.1.3. R&D of spirulina as commercial products
3.10.2. Restraints
3.10.2.1. Impact on spirulina production due to climate change
3.10.3. Opportunities
3.10.3.1. Untapped markets in the developing countries
3.10.3.2. Easy to cultivate due to development in cultivation technology
CHAPTER 4: SPIRULINA MARKET, BY TYPE
4.1. Overview
4.1.1. Market size and forecast
4.2. Arthrospira Platensis
4.2.1. Key market trends and opportunities
4.2.2. Market size and forecast
4.2.3. Market analysis, by country
4.3. Arthrospira Maxima
4.3.1. Key market trends and opportunities
4.3.2. Market size and forecast
4.3.3. Market analysis, by country
CHAPTER 5: SPIRULINA MARKET, BY APPLICATION
5.1. Overview
5.1.1. Market size and forecast
5.2. Nutraceuticals
5.2.1. Key market trends and opportunities
5.2.2. Market size and forecast
5.2.3. Market analysis, by country
5.3. Cosmetics
5.3.1. Key market trends and opportunities
5.3.2. Market size and forecast
5.3.3. Market analysis, by country
5.4. Food and Beverages
5.4.1. Key market trends and opportunities
5.4.2. Market size and forecast
5.4.3. Market analysis, by country
5.5. Animal Feed
5.5.1. Key market trends and opportunities
5.5.2. Market size and forecast
5.5.3. Market analysis, by country
5.6. Other applications
5.6.1. Key market trends and opportunities
5.6.2. Market size and forecast
5.6.3. Market analysis, by country
CHAPTER 6: SPIRULINA MARKET, BY DRUG FORMULATION
6.1. Overview
6.1.1. Market size and forecast
6.2. Powder
6.2.1. Key market trends and opportunities
6.2.2. Market size and forecast
6.2.3. Market analysis, by country
6.3. Tablet & Capsule
6.3.1. Key market trends and opportunities
6.3.2. Market size and forecast
6.3.3. Market analysis, by country
6.4. Liquid
6.4.1. Key market trends and opportunities
6.4.2. Market size and forecast
6.4.3. Market analysis, by country
6.5. Granule & Gelling Agent
6.5.1. Key market trends and opportunities
6.5.2. Market size and forecast
6.5.3. Market analysis, by country
CHAPTER 7: SPIRULINA MARKET, BY REGION
7.1. Overview
7.1.1. Market size and forecast
7.2. North America
7.2.1. Key market trends and opportunities
7.2.2. North America market size and forecast, by type
7.2.3. North America market size and forecast, by application
7.2.4. North America market size and forecast, by drug formulation
7.2.5. North America market size and forecast, by country
7.2.5.1. U.S. market size and forecast, by type
7.2.5.2. U.S. market size and forecast, by application
7.2.5.3. U.S. market size and forecast, by drug formulation
7.2.5.4. Canada market size and forecast, by type
7.2.5.5. Canada market size and forecast, by application
7.2.5.6. Canada market size and forecast, by drug formulation
7.2.5.7. Mexico market size and forecast, by type
7.2.5.8. Mexico market size and forecast, by application
7.2.5.9. Mexico market size and forecast, by drug formulation
7.3. Europe
7.3.1. Key market trends and opportunities
7.3.2. Europe market size and forecast, by type
7.3.3. Europe market size and forecast, by application
7.3.4. Europe market size and forecast, by drug formulation
7.3.5. Europe market size and forecast, by country
7.3.5.1. France market size and forecast, by type
7.3.5.2. France market size and forecast, by application
7.3.5.3. France market size and forecast, by drug formulation
7.3.5.4. UK market size and forecast, by type
7.3.5.5. UK market size and forecast, by application
7.3.5.6. UK market size and forecast, by drug formulation
7.3.5.7. Italy market size and forecast, by type
7.3.5.8. Italy market size and forecast, by application
7.3.5.9. Italy market size and forecast, by drug formulation
7.3.5.10. Spain market size and forecast, by type
7.3.5.11. Spain market size and forecast, by application
7.3.5.12. Spain market size and forecast, by drug formulation
7.3.5.13. Rest of Europe market size and forecast, by type
7.3.5.14. Rest of Europe market size and forecast, by application
7.3.5.15. Rest of Europe market size and forecast, by drug formulation
7.4. Asia-Pacific
7.4.1. Key market trends and opportunities
7.4.2. Asia-Pacific market size and forecast, by type
7.4.3. Asia-Pacific market size and forecast, by application
7.4.4. Asia-Pacific market size and forecast, by drug formulation
7.4.5. Asia-Pacific market size and forecast, by country
7.4.5.1. Japan market size and forecast, by type
7.4.5.2. Japan market size and forecast, by application
7.4.5.3. Japan market size and forecast, by drug formulation
7.4.5.4. China market size and forecast, by type
7.4.5.5. China market size and forecast, by application
7.4.5.6. China market size and forecast, by drug formulation
7.4.5.7. India market size and forecast, by type
7.4.5.8. India market size and forecast, by application
7.4.5.9. India market size and forecast, by drug formulation
7.4.5.10. Australia market size and forecast, by type
7.4.5.11. Australia market size and forecast, by application
7.4.5.12. Australia market size and forecast, by drug formulation
7.4.5.13. South Korea market size and forecast, by type
7.4.5.14. South Korea market size and forecast, by application
7.4.5.15. South Korea market size and forecast, by drug formulation
7.4.5.16. Rest of Asia-Pacific market size and forecast, by type
7.4.5.17. Rest of Asia-Pacific market size and forecast, by application
7.4.5.18. Rest of Asia-Pacific market size and forecast, by drug formulation
7.5. LAMEA
7.5.1. Key market trends and opportunities
7.5.2. LAMEA market size and forecast, by type
7.5.3. LAMEA market size and forecast, by application
7.5.4. LAMEA market size and forecast, by drug formulation
7.5.5. LAMEA market size and forecast, by country
7.5.5.1. Brazil market size and forecast, by type
7.5.5.2. Brazil market size and forecast, by application
7.5.5.3. Brazil market size and forecast, by drug formulation
7.5.5.4. South Africa market size and forecast, by type
7.5.5.5. South Africa market size and forecast, by application
7.5.5.6. South Africa market size and forecast, by drug formulation
7.5.5.7. Rest of LAMEA market size and forecast, by type
7.5.5.8. Rest of LAMEA market size and forecast, by application
7.5.5.9. Rest of LAMEA market size and forecast, by drug formulation
CHAPTER 8: COMPANY PROFILES
8.1. Algenol Biofuels Inc.
8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Operating business segments
8.1.4. Product portfolio
8.2. Dongtai City Spirulina Bio-engineering Co, Ltd.
8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Operating business segments
8.2.4. Product portfolio
8.3. CHR. HANSEN HOLDING A/S
8.3.1. Company overview
8.3.2. CHR. Hansen: company Snapshot
8.3.3. Operating business segments
8.3.4. Product portfolio
8.3.5. Business performance
8.4. CYANOTECH CORPORATION
8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segments
8.4.4. Product portfolio
8.4.5. Business performance
8.5. DDW Inc.
8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Operating business segments
8.5.4. Product portfolio
8.6. DIC CORPORATION
8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Operating business segments
8.6.4. Product portfolio
8.6.5. Business performance
8.7. DHLER GMBH
8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Operating business segments
8.7.4. Product portfolio
8.8. FMC CORPORATION
8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Operating business segments
8.8.4. Product portfolio
8.8.5. Business performance
8.8.6. Key strategic moves and developments
8.9. Givaudan International SA
8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Operating business segments
8.9.4. Product portfolio
8.9.5. Business performance
8.9.6. Key strategic moves and developments
8.10. KONINKLIJKE DSM N.V.
8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Operating business segments
8.10.4. Product portfolio
8.10.5. Key strategic moves and developments
8.11. Prolgae
8.11.1. Company overview
8.11.2. Company snapshot
8.11.3. Operating business segments
8.11.4. Product portfolio
8.11.5. Business performance
8.12. SENSIENT TECHNOLOGIES CORPORATION
8.12.1. Company overview
8.12.2. Company snapshot
8.12.3. Operating business segments
8.12.4. Product portfolio
8.12.5. Business performance
8.13. E.I.D. Parry Limited
8.13.1. Company overview
8.13.2. Company snapshot
8.13.3. Operating business segments
8.13.4. Product portfolio
8.13.5. Business performance
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
